Search

Your search keyword '"Yaouanq, J."' showing total 141 results

Search Constraints

Start Over You searched for: Author "Yaouanq, J." Remove constraint Author: "Yaouanq, J."
141 results on '"Yaouanq, J."'

Search Results

6. A second-generation genomic screen for multiple sclerosis

8. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

13. Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

14. The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL

15. Health-related quality of life in multiple sclerosis: Effects of natalizumab

16. The incidence and significance of anti-natalizumab antibodies. Results from the AFFIRM and SENTINEL

17. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

20. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

23. Reply to Worwood et al

26. Combined segregation and linkage analysis of genetic hemochromatosis using affection status, serum iron, and HLA

33. ‘Clinically definite benign multiple sclerosis’, an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.

36. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.

38. Significance of Interleukin-1β and Interleukin-1 Receptor Antagonist Genetic Polymorphism in Inflammatory Bowel Diseases.

40. A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association

41. Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE)

45. Small-area distribution of multiple sclerosis incidence in western France: in search of environmental triggers.

46. REEP1 mutations in SPG31: frequency, mutational spectrum, and potential association with mitochondrial morpho-functional dysfunction.

47. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

48. Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis.

49. Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study.

50. NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype- phenotype analysis.

Catalog

Books, media, physical & digital resources